دورية أكاديمية
5072 Independent central review of clinical benefit rates in FIRST: a Phase II comparison of fulvestrant 500 mg with anastrozole 1 mg as first-line endocrine therapy for postmenopausal women with hormone receptor positive advanced breast cancer
| العنوان: | 5072 Independent central review of clinical benefit rates in FIRST: a Phase II comparison of fulvestrant 500 mg with anastrozole 1 mg as first-line endocrine therapy for postmenopausal women with hormone receptor positive advanced breast cancer |
|---|---|
| المؤلفون: | Lindemann, J.P.O., Robertson, J.F.R., Ellis, M.J., Menu, Y., Macpherson, E.J., Ghiorghiu, D.D.C. |
| المصدر: | In EJC Supplements 2009 7(2):282-282 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 13596349 |
|---|---|
| DOI: | 10.1016/S1359-6349(09)70964-4 |